/PRNewswire/ NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases,.
-Visit OBiO Tech booth #1644 at American Society of Gene & Cell Therapy in Maryland, USA SHANGHAI, April 28, 2024 /PRNewswire/ — OBiO Technology (Shanghai) Corp., Ltd. (OBiO, 688238.SH), a world leading contract development and manufacturing organization for cell and gene therapy, will showcase at American Society of Gene & Cell Therapy in Maryland, USA from May 7th to 11th. 9 posters will […]
According to Market.us, the Proteinase K Market Size is expected to achieve an approximate value of USD 10.4 billion by the year 2033, reflecting a significant surge from its 2023 valuation of USD 4.5 billion. This growth trajectory is forecasted to unfold at a Compound Annual Growth Rate (CAGR) of 8.8% during the f.
-Visit OBiO Tech booth #1644 at American Society of Gene & Cell Therapy in Maryland, USA SHANGHAI, April 28, 2024 /PRNewswire/ OBiO Technology (Shanghai) Corp., Ltd. (OBiO, 688238.SH), a world leading contract
/PRNewswire/ OBiO Technology (Shanghai) Corp., Ltd. (OBiO, 688238.SH), a world leading contract development and manufacturing organization for cell and gene.